Skip to content

Effect on Postoperative Sore Throat of Lidocaine Jelly Application Over the Endotracheal Tube of Tapered-shaped Cuff

Effect on Postoperative Sore Throat of Lidocaine Jelly Application Over the Endotracheal Tube of Tapered-shaped Cuff

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02952157
Enrollment
210
Registered
2016-11-02
Start date
2016-11-30
Completion date
2016-11-30
Last updated
2016-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sore Throat

Brief summary

Postoperative sore throat is a complication after general anesthesia requiring endotracheal intubation. The investigators will evaluate the efficacy of lidocaine jelly application on the endotracheal tube with taper-shaped cuff regarding postoperative sore throat.

Interventions

DRUGLidocaine jelly application
DRUGNormal saline application

Sponsors

Keimyung University Dongsan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-III * Patients scheduled for general anesthesia with endotracheal intubation * Patients scheduled for surgery which duration is expected to less than 3 hr

Exclusion criteria

* Difficult airway * Rapid sequence induction * Recent sore throat * Recent upper respiratory infection * Asthma * Chronic obstructive pulmonary disease * Chronic cough * Pregnancy * Allergy to lidocaine * Friable teeth * History of head and neck surgery * Multiple intubation attempts * Regional anesthetic agents * Gastric tube * Dexamethasone

Design outcomes

Primary

MeasureTime frame
Number of participants with sore throatAt 24 hr

Secondary

MeasureTime frame
Number of participants with hoarsenessAt 1, 6, 12 and 24 hr
Number of participants with throat numbnessAt 1, 6, 12 and 24 hr
Number of participants with nauseaAt 1, 6, 12 and 24 hr
Number of participants with sore throatAt 1, 6, and 12 hr
Number of participants with coughAt 1, 6, 12 and 24 hr
Number of participants with dry mouthAt 1, 6, 12 and 24 hr
Number of participants with additional pain medicationAt 24 hr
Number of participants with vomitingAt 1, 6, 12 and 24 hr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026